| Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis R Orlando, M Mussap, M Plebani, P Piccoli, S De Martin, M Floreani, ... Clinical chemistry 48 (6), 850-858, 2002 | 211 | 2002 |
| Etiopathogenesis of autoimmune hepatitis A Floreani, P Restrepo-Jiménez, MF Secchi, S De Martin, PSC Leung, ... Journal of autoimmunity 95, 133-143, 2018 | 165 | 2018 |
| Cytochrome P450 1A2 is a major determinant of lidocaine metabolism in vivo: effects of liver function R Orlando, P Piccoli, S De Martin, R Padrini, M Floreani, P Palatini Clinical Pharmacology & Therapeutics 75 (1), 80-88, 2004 | 130 | 2004 |
| Antibiotic‐induced dysbiosis of the microbiota impairs gut neuromuscular function in juvenile mice V Caputi, I Marsilio, V Filpa, S Cerantola, G Orso, M Bistoletti, ... British journal of pharmacology 174 (20), 3623-3639, 2017 | 107 | 2017 |
| Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis S De Martin, R Orlando, M Bertoli, P Pegoraro, P Palatini Clinical Pharmacology & Therapeutics 80 (6), 597-606, 2006 | 93 | 2006 |
| Pharmacokinetic drug interactions in liver disease: an update P Palatini, S De Martin World Journal of Gastroenterology 22 (3), 1260, 2016 | 91 | 2016 |
| Depression and cognitive impairment—extrahepatic manifestations of NAFLD and NASH M Colognesi, D Gabbia, S De Martin Biomedicines 8 (7), 229, 2020 | 75 | 2020 |
| The Phytocomplex from Fucus vesiculosus and Ascophyllum nodosum Controls Postprandial Plasma Glucose Levels: An In Vitro and In Vivo Study in a Mouse … D Gabbia, S Dall’Acqua, IM Di Gangi, S Bogialli, V Caputi, L Albertoni, ... Marine Drugs 15 (2), 41, 2017 | 74 | 2017 |
| Effect of the CYP3A4 inhibitor erythromycin on the pharmacokinetics of lignocaine and its pharmacologically active metabolites in subjects with normal and impaired liver function R Orlando, P Piccoli, S De Martin, R Padrini, P Palatini British journal of clinical pharmacology 55 (1), 86-93, 2003 | 71 | 2003 |
| REL-1017 (esmethadone) as adjunctive treatment in patients with major depressive disorder: a phase 2a randomized double-blind trial M Fava, S Stahl, L Pani, S De Martin, M Pappagallo, C Guidetti, A Alimonti, ... American Journal of Psychiatry 179 (2), 122-131, 2022 | 65 | 2022 |
| The role of oxidative stress in NAFLD–NASH–HCC transition—focus on NADPH oxidases D Gabbia, L Cannella, S De Martin Biomedicines 9 (6), 687, 2021 | 63 | 2021 |
| NAD+-dependent SIRT1 deactivation has a key role on ischemia–reperfusion-induced apoptosis A Cattelan, G Ceolotto, S Bova, M Albiero, M Kuppusamy, S De Martin, ... Vascular Pharmacology 70, 35-44, 2015 | 63 | 2015 |
| Extrahepatic autoimmunity in autoimmune liver disease A Floreani, S De Martin, MF Secchi, N Cazzagon European journal of internal medicine 59, 1-7, 2019 | 57 | 2019 |
| Dexamethasone counteracts hepatic inflammation and oxidative stress in cholestatic rats via CAR activation D Gabbia, L Pozzo, G Zigiotto, M Roverso, D Sacchi, A Dalla Pozza, ... PloS one 13 (9), e0204336, 2018 | 50 | 2018 |
| In vitro and in vivo behavior of liposomes decorated with PEGs with different chemical features F Mastrotto, C Brazzale, F Bellato, S De Martin, G Grange, ... Molecular pharmaceutics 17 (2), 472-487, 2019 | 49 | 2019 |
| Brown seaweeds for the management of metabolic syndrome and associated diseases D Gabbia, S De Martin Molecules 25 (18), 4182, 2020 | 47 | 2020 |
| Western diet-induced metabolic alterations affect circulating markers of liver function before the development of steatosis D Gabbia, M Roverso, M Guido, D Sacchi, M Scaffidi, M Carrara, G Orso, ... Nutrients 11 (7), 1602, 2019 | 40 | 2019 |
| Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2–mediated theophylline metabolism by fluvoxamine R Orlando, R Padrini, M Perazzi, S De Martin, P Piccoli, P Palatini Clinical Pharmacology & Therapeutics 79 (5), 489-499, 2006 | 36 | 2006 |
| The Cuban propolis component nemorosone inhibits proliferation and metastatic properties of human colorectal cancer cells Y Frión-Herrera, D Gabbia, M Scaffidi, L Zagni, O Cuesta-Rubio, ... International Journal of Molecular Sciences 21 (5), 1827, 2020 | 34 | 2020 |
| Co-administration of sirolimus alters tacrolimus pharmacokinetics in a dose-dependent manner in adult renal transplant recipients N Baldan, P Rigotti, L Furian, G Margani, B Ekser, L Frison, S De Martin, ... Pharmacological research 54 (3), 181-185, 2006 | 33 | 2006 |
